Join this panel discussion at Kadans Science Partner's PLUS ULTRA Leiden to level up your skills through peer-to-peer discussions and get a sneak peek into the biggest solutions designed to accelerate and innovate science.
Benchtalk Series is the ideal place for content sharing, connection, and local scientific community building. At these free events, like-minded scientific professionals come together to accelerate the speed and impact of biotech R&D and walk away with new ideas and insights to get the most out of their work.
We know it’s rare to get out of the lab and be face to face with your peers. Join us to connect with your colleagues—in real life—and have conversations that inspire new thinking to take back to the bench.
When it comes to science, discovery never ends. At Benchtalk Series, you’ll level up your skills through peer-to-peer discussions and get a sneak peek into the biggest solutions designed to accelerate and innovate science.
Your work is hard and celebrating breakthroughs doesn't often happen easily. Come to Benchtalk Series to relax, unwind, and have some fun. We promise good food and ample networking.
Check-in, have coffee, and get to know other guests before the event starts.
Kelli Grand, Implementation Manager, Benchling
Meritxell Orpinell, Leader - Professional Services, Benchling
Willi Gottstein, Scientist, DSM
DSM is a global purpose-led, science-based company specializing in Nutrition, Health & Sustainable Living. Our purpose is to create brighter lives for all. We achieve it by using all the scientific and innovation power at our disposal to tackle some of the world’s greatest challenges. In this presentation we will briefly illustrate how innovation can be accelerated and improved through the combination of lab automation and AI.
Tobias Wingbermühle, Chief Commercial Officer, Clustermarket
Laboratories are one sector that can benefit most from standardization, especially when it comes to performance. Without strict guidelines or standards to abide by, labs are often forced to rely on themselves to figure out how to produce not just a high volume of relevant results but reproducible ones too. The difficulty with standardizing KPIs stems from the nature of scientific research, as performance criteria are nearly always different from lab to lab. With that in mind, there are still a few key performance indicators (KPIs) relevant to the scientific continuum, complete with optimised methods of analysing and reporting them to help assess your lab’s level of efficiency.
Andrew Smith | Leader, Business Development, Benchling
In vivo studies are an essential component of biopharmaceutical R&D that help teams understand drug pharmacology, safety, and toxicology. They sit on the critical path to bringing new drugs into the clinic, so it’s imperative to run them accurately, efficiently, and collaboratively. Yet many teams still struggle to manage the end-to-end process of running in vivo studies using spreadsheets, email, and outdated point solutions. Modern drug development teams require an in vivo solution that aligns with the specialized nature of vivarium work, yet also remains connected to their broader R&D programs. In this session, we will share some of the frequent challenges observed across the industry, followed by real-world examples of companies modernizing their in vivo programs. We'll provide insights on how to drive collaboration across R&D teams and accelerate time to clinic by leveraging connected, cloud-based R&D applications that facilitate sample transfers for bioanalysis and joining of data for scientific decision-making.
In need of some more hands-on support or a solution to manage multiple labs?
Check out Clustermarket's paid subscription here.
